Afuco™ Anti-Human FOLR2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-FOLR2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a FR-β monoclonal antibody used for treating rheumatoid arthritis, juvenile rheumatoid arthritis, macrophage activation syndrome, septicemia, and FR-β expressing leukemia, which induces apoptosis in activated macrophages and folate receptor beta (FR-β) expressing leukemia cells to specifically destroy these cells.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-281CL |
| Pricing | Inquiry |
| Host | Human |
| Target | FOLR2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |